Cricoid Pressure for Acid Reflux
(SE-GERD Trial)
Trial Summary
What is the purpose of this trial?
After defining the manometric characteristics of UES incompetence associated with documented pharyngeal reflux, we will determine the reproducibility of manometric criteria for UES incompetence in prevention of pharyngeal reflux. We hypothesize that these criteria are comprised of either a single or constellation of manometric abnormalities. After determining the ability of externally applied cricoid cartilage pressure in preventing pharyngeal reflux, we further hypothesize that this approach will eliminate or reduce esophago-pharyngeal reflux by enhancing the UES pressure barrier. We anticipate there will be a close spatial correlation between the site of applied pressure and area of increased pressure within UES high pressure zone. Lastly, we will determine and characterize the effect of externally applied cricoid cartilage pressure on related functions such as belch and swallow, testing the hypothesis that these functions will not be impaired.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Externally Applied Cricoid Cartilage Pressure for acid reflux?
Is cricoid pressure safe for humans?
How does the treatment of Externally Applied Cricoid Cartilage Pressure for acid reflux differ from other treatments?
Research Team
Reza Shaker, MD
Principal Investigator
Medical College of Wisconsin
Eligibility Criteria
This trial is for GERD patients with regurgitation and supra-esophageal symptoms, based on American Gastroenterological Association guidelines. It's not for those under 20 or over 85, with a history of alcohol/drug abuse, certain GI/ENT/pulmonary diseases, inability to consent, pregnancy, cancer treatments history, or Lidocaine allergy.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Diagnostic Testing
Participants undergo transnasal esophagogastroduodenoscopy (T-EGD) and pH monitoring to verify GERD presence, followed by manometric and impedance testing.
Treatment
Participants receive externally applied cricoid cartilage pressure to prevent pharyngeal reflux and undergo various infusion tests.
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessment of UES pressure response and esophageal clearance.
Treatment Details
Interventions
- Externally Applied Cricoid Cartilage Pressure
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical College of Wisconsin
Lead Sponsor